Presenting companies comprising early stage and biotech are on the program for the sixth annual Biotech Showcase investor and partnering conference taking place in According to a release, the event, held through
More than 200 investment companies are slated to attend with over 300 individual investors on the roster. Large pharmaceutical companies sponsoring the event will bring teams of investment and business development executives, including
In addition, this year's program features several investment strategy-focused panels:
-"Biotech Showcase, Streetwise Reports and Sagient Research Present The Life Sciences Report Watchlist 2014," a presentation by industry analysts, will give an exclusive insider's overview of stocks and sectors to watch in the coming year.
-"Sources of Alternative Funding in Difficult Times" will feature speakers from investment and securities firms who will discuss the current investment environment for start-up medical technology companies and new funding strategies, including alternative funding sources for pre-revenue and emerging companies.
-Of special interest to internationally-minded biotech, the BaselArea incubator will present "
-And the fourth annual
"Regenerative medicine is dedicated to innovation. By providing living cell therapies for a global population, we can help to improve the lives of patients dealing with everything from heart disease to diabetic ulcers. The efforts of ARM are important in promoting this growing sector. We are excited about the panel-the thought leaders in regenerative medicine will be providing projections for the year ahead," said
Biotech Showcase is powered by partneringONE, a partnering system that enables delegates to identify and arrange meetings with potential investors and partners.
View the program and register online.
About Biotech Showcase 2014:
Biotech Showcase is an investor and partnering conference devoted to providing private and small- and mid-cap biotechnology companies an opportunity to present to and meet with investors and biopharmaceutical executives during the course an annual healthcare conference that attracts investors and biopharmaceutical executives from around the world.
The 2013 edition showed a substantial increase in the number of presenting companies, as well as significant growth in the number of attendees and one-to-one meetings. The 2013 event featured corporate presentations by 236 public and private biotechnology and life science companies, and drew 1,600 delegates who engaged in 2,500 one- to-one meetings.
((Comments on this story may be sent to firstname.lastname@example.org))
Presenting companies comprising early stage and biotech are on the program for the sixth annual Biotech Showcase investor and partnering conference taking place in
According to a release, the event, held through